Session 3A
Cassio Pedroso, Cheryl Tajon
The interfaces among biology, chemistry, physics, and engineering are crucial for the rational design of nanodevices and biosensors to identify the onset of disease and develop therapeutics. A variety of nanomaterials have been developed to treat cancer, uncover bacterial infection, and recently detect SARS-CoV-2. This symposium will bring together researchers involved in cross-disciplinary work to showcase cutting-edge technologies and foster collaboration and new directions in medicine.
Session Schedule:
(abstracts below)
10:00-10:30 am
Talking to cells: biomolecular engineering for non-invasive imaging and control of cellular function
Mikhail Shapiro, California Institute of Technology
10:30-10:50 am
Brominated nanoscale diamond enables room temperature and catalysis free functionalization chemistry
Abraham Wolcott, San Jose State University
10:50-10:55 am
Break 1
10:55-11:25 am
Optical Nanosensors for the Identification of Disease and Therapeutic Vulnerabilities
Daniel Heller, Memorial Sloan Kettering Cancer Center
11:25-11:45 am
Upconverting Nanoparticles for Chip-Scale Cancer Imaging
Mekhail Anwar, UC San Francisco
11:45-11:50 am
Break 2
11:50-12:20 pm
Measuring and improving the speed of RNA-based devices for detection and treatment
Ming Hammond, University of Utah
12:20-12:30 pm
New label free interaction instrumentation in the Biological Nanostructures Facility
Michael Connolly, The Molecular Foundry, LBNL